glp-1 and dpp-4 inhibitors The Role of in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect GLP-1 receptor agonists or DPP-4

However, in people with type 2 diabetes, GIP does not contribute at all to the total insulin secretion effect of the combination while the insulinotropic effect of GLP-1 is only slightly impaired

For more information, visit www.hims.com/weight-loss or www.forhers.com/weight-loss Assets Download Contact Abby Reisinger-Moley [email protected] 1 Access to Zepbound and Foundayo does not imply a partnership or affiliation with Eli Lilly and Company

89 specifically in obese patients with T2D who were treated with varying doses of Liraglutide

Z.WhiteJ

Gastroenterology 89:10701077 Ritzel U, Fromme A, Ottleben M, Leonhardt U, Ramadori G (1997) Release of glucagon-like peptide-1 (GLP-1) by carbohydrates in the perfused rat ileum